Skip to content

Optimizing TMS Arousal Strategies via the Cortical-Thalamic Circuit: Exploring Mechanisms to Clinical Applications

Optimizing TMS Arousal Strategies via the Cortical-Thalamic Circuit: Exploring Mechanisms to Clinical Applications

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126995
Enrollment
Unknown
Registered
2026-06-22
Start date
2025-12-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorder of Consciousness

Interventions

Simple Sound Stimulation Group and Familiar Person's Voice Stimulation:The conversation sessions followed a structured design, encompassing the review of personal information, sharing of fond memories
Combined Auditory and Active TMS Stimulation:The iTBS intervention was administered using a Magstim Rapid2 Plus 1 TMS device equipped with a double-cone 8-coil, integrated with the Brainsight 2.0 neur
Combined Auditory and Sham TMS Stimulation:Received the identical protocol but using a sham TMS coil.

Sponsors

Yancheng First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Basic Criteria: Aged 18-80 years; coma duration of 7-90 days; Glasgow Coma Scale (GCS) score of 3-8; Revised Coma Recovery Scale (CRS-R) score of 5-15; and relatively stable vital signs. 2. Imaging Requirements: Cranial CT or MRI demonstrating relatively intact brain structure, absence of severe damage in the prefrontal cortex and thalamic regions, and no significant signs of cerebral herniation or increased intracranial pressure. 3. Additional Criteria: Informed consent signed by family members; life expectancy >= 3 months; and ability to cooperate with completing the relevant examinations.

Exclusion criteria

Exclusion criteria: 1. Device-related factors: including implanted electronic devices (e.g., cardiac pacemakers, defibrillators), intracranial metal objects, or inner ear implants/cochlear implants. 2. Disease-related factors: including a history of epilepsy or epileptiform discharges on EEG; severe cardiac, hepatic, or renal dysfunction; malignant tumors or a life expectancy of <6 months; and a history of severe psychiatric disorders. 3. Other factors: such as pregnancy or lactation; current participation in other clinical trials; and unwillingness of family members to provide consent for the study.

Design outcomes

Primary

MeasureTime frame
CRS-R Score;

Secondary

MeasureTime frame
Montreal Cognitive Assessment;Mini-Mental State Examination;Fugl-Meyer Assessment of Motor Recovery;Berg Balance Scale;Functional Independence Measure;Modified Rankin Scale;Electroencephalogram;Magnetic Resonance Imaging;

Countries

China

Contacts

Public ContactLu Zhongqian

Yancheng First People's Hospital

luzhongqian1976@163.com+86 188 6198 3113

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026